Company profile
iBio company profile
iBio develops and offers product applications of its iBioLaunch™ and iBioModulator™ platforms, providing collaborators full support for turn-key implementation of its technology for both proprietary and biosimilar products. The iBioLaunch platform is a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. Advantages over other systems include: success with proteins difficult or impossible to produce with other methods; broadly applicable to biologics, including monoclonal antibodies, other therapeutic proteins and vaccines; enables rapid development and validation of modular, scalable, and optionally robotic, multi-product manufacturing facilities; production time measured in weeks instead of months..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://ibioinc.com
- Phone number
- 302-355-0650
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $0+
- Founded
- 2008-04-01
Headquarters
- Headquarters
- Mala Mechetnya, Mykolaiv, Ukraine
- Postal code
- 19711
- Country code
- UA
- Continent
- Europe